학술논문
Current Status and Perspectives of Tyrosine Kinase Inhibitor Treatment in the Posttransplant Period in Patients with Chronic Myelogenous Leukemia (CML)
Document Type
Review Article
Author
Source
In Biology of Blood and Marrow Transplantation 2010 16(3):301-310
Subject
Language
ISSN
1083-8791